2013 YEAR IN REVIEW

January 2013

  • U.S. News and World Report selected the DASH diet as the #1 best diet overall in America for 2013, for the third consecutive year.  Pennington Biomedical was a key contributor to the NIH-funded DASH studies, led by Drs. George Bray and Catherine Champagne
  • Pennington Biomedical’s Dr. Steven Heymsfield was part of an international team of researchers that contributed to a study published in the New England Journal of Medicine (NEJM) that dispelled obesity myths that are leading to poor policy decisions, inaccurate public health recommendations, and wasted resources

February 2013

  • Pennington Division of Education hosted 50 researchers from around the world for another conference in its Pennington Scientific Symposium Series.  The February program, Botanicals and Translational Medicine, was co-chaired by Pennington Biomedical Researchers Drs. William Cefalu and Jacqueline Stephens

May 2013

  • Jeffrey M. Friedman, M.D., Ph.D. received an honorary doctorate degree from LSU Health Sciences Center for his internationally recognized research on obesity

June 2013

  • Pennington Biomedical announced it will take part in a National Institutes of Health (NIH)-funded study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.  The project is called the Glycemia Reduction Approaches in Diabetes:  A Comparative Effectiveness (GRADE) Study
  • Dr. Steven Heymsfield steps down as Executive Director of Pennington Biomedical Research Center to resume his research interests full time at the Center.  Heymsfield, recognized as one of the world’s leading obesity researchers, is credited with placing greater focus on Pennington Biomedical’s industry and commercialization efforts
  • Dr. William Cefalu, the Douglas L. Manship, Sr. Professor of Diabetes, was appointed as the new Executive Director of Pennington Biomedical Research Center.  Most recently he served as Chief Scientific Officer of Pennington Biomedical, while also lending his leadership efforts as Chief, Joint Program on Diabetes, Endocrinology and Metabolism, a joint academic program of Pennington Biomedical and the LSU Health Sciences Center School of Medicine in New Orleans.  Additionally, Dr. Cefalu serves as Editor-in-Chief for the journal Diabetes Care, the primary clinical research journal of the American Diabetes Association

July 2013

  • Pennington Biomedical researchers contributed to an ancillary study associated with Look AHEAD (Action for Health in Diabetes) that found a long-term intensive lifestyle intervention program, focused on weight loss, can improved physical quality of life, reduce microvascular complications, lower the risk of depression and lower medical costs by reducing the need for hospitalizations, outpatient care and medications for obese people with type 2 diabetes.  The information was presented at the American Diabetes Association’s 73rd Scientific Sessions.

October 2013

  • Pennington Biomedical announced it will take part in the first definitive, large-scale National Institutes of Health (NIH)-clinical trial to investigate if a vitamin D supplement helps prevent or delay type 2 diabetes in adults who have prediabetes
  • Pennington Biomedical researcher Dr. Peter Katzmarzyk was appointed as the Marie Edana Corcoran Endowed Chair in Pediatric Obesity and Diabetes

December 2013

  • Pennington Biomedical was awarded two new military research and health promotion grants of nearly $16 million to support optimal nutrition, fitness, combat readiness, Warfighter performance and resilience.  The funding was awarded to Pennington Biomedical by the United States Department of Defense (DoD) in collaboration with the Telemedicine and Advanced Technology Research Center (TATRC) and the US Army Research Institute of Environmental Medicine (USARIEM)
  • Pennington Biomedical successfully completed an accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its clinical research program

Educational & Community Programs
February 2013

  • Pennington Biomedical hosted the 11th Annual Irene W. Pennington Wellness Day for Women, a community event for women with free health screenings and educational seminars

July 2013

  • Pennington Biomedical hosted the 2nd Annual Parkinson’s Conference.  More than 400 Parkinson’s patients, caregivers and providers attended.

 August 2013

  • Pennington Biomedical was the host site for the 12th Annual Louisiana Men’s Health Conference, which provided men of all ages an opportunity to explore ways to better care for themselves and their health

October 2013

  • Pennington Biomedical hosted the 6th Annual Childhood Obesity & Public Health Conference led by Dr. Peter Katzmarzyk.  More than 400 public health professionals, educators, and business leaders attended